Lenalidomide Grindeks

Medicinal product

(Invented) name

Lenalidomide Grindeks

Active substance (s)

Lenalidomidas

Strength

7,5 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AX04, Lenalidomide

Marketing authorisation holder

AS Grindeks, Latvija

Date of authorisation

2019-10-11

Date of renewal

2024-10-09

Documents

Brosiura_pacientui_vyrai.pdf

Brosiura_sveikatos_prieziuros_specialistams.pdf

Paciento kortele.pdf

4449_4455 Pakuotės lapelis 2025 08 28.docx

Brosiura_pacientui_nevaisingos_moterys.pdf

Kontrolinis_sarasas_vaisingos_moterys.pdf

Kontrolinis_sarasas_nevaisingos_moterys.pdf

Brosiura_pacientui_vaisingos_moterys.pdf

4449_4455 Lenalidomide Grindeks PL 2025 08 28.docx

Kontrolinis_sarasas_vyrai.pdf

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/4286/003/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Lenalidomidas	7,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102500	88601	1088601	lizdinė plokštelė	N7		Receptinis	LT/1/19/4451/001	Netiekiama	-	-	No	-	-
102501	88602	1088602	lizdinė plokštelė	N21		Receptinis	LT/1/19/4451/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-10-09	Perregistruotas
2019-10-11	Registruotas